Medclair AB (NGM:MCLR)

Market Cap	259.36M -5.6%
Revenue (ttm)	53.14M +34.9%
Net Income	1.48M -27.1%
EPS	0.02 -38.2%
Shares Out	91.65M
PE Ratio	157.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,145
Open	n/a
Previous Close	2.810
Day's Range	n/a
52-Week Range	2.200 - 3.340
Beta	0.76
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 2, 2026

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O) in Sweden. It offers mobile destruction unit, a mobile unit that enables the destruction of nitrous oxide; central destruction unit, an ideal solution for situations where Nitrous Oxide (N2O) is used simultaneously in multiple treatment rooms; Recycling Decomposition Unit, an intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O canisters and decomposes it within a self-supporting sy...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 21
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 29, 2026

Data Sources Report a data error